Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
annum, arraignment, ascertain, BioCellgraft, CEO, cGMP, cGTP, conclusion, confirmed, constrained, covenant, debtor, deficiency, delisting, delta, dental, desk, eligible, enhance, forbearance, forebear, gamma, inspection, inspectional, interrelated, metric, notification, obsolescence, paused, pertain, potency, precision, proceeding, produce, proliferation, receipt, reevaluate, Regeneron, rendered, rental, resolution, response, shown, split, timeframe, training, twelve, unaffiliated, unenforceable
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view